From theheart.org on Medscape

Coverage from the

European Society of Cardiology (ESC) Congress 2018

August 25 - 29, 2018; Munich, Germany

August 25 - 29, 2018 Munich, Germany

ESC 2018 Switch to Oral Antibiotics Safe in Left-Sided Endocarditis The POET trial met its noninferiority composite endpoint and cut hospital stays, opening the door to a new approach to a costly and thorny cardiac problem.
Medscape Medical News, August 29, 2018
ESC 2018 Extended Ticagrelor Monotherapy After Stenting Misses Endpoint A novel antiplatelet regimen of extended ticagrelor monotherapy with aspirin added just for the first month after stenting narrowly failed to show superiority over standard treatment in the GLOBAL LEADERS trial.
Medscape Medical News, August 27, 2018
ESC 2018 ATTR-ACT: Tafamidis Reduces Mortality in Amyloid Cardiomyopathy A drug that binds transthyretin reduced all-cause mortality and cardiovascular hospitalizations and slowed decline in functional capacity in patients with transthyretin amyloid cardiomyopathy.
Medscape Medical News, August 27, 2018

Meeting Highlights

Cardio Twitter Brings ESC Congress to the Masses #CardioTwitter had a strong pulse at the European Society of Cardiology meeting.
Top News From ESC 2018: Slideshow Headlines from the world's largest cardiology meeting include surprising negative trials of fish oil supplements and aspirin for cardiovascular prevention.

Conference News

ESC 2018 Start With Multi-Med Single Pill: New European HTN Guidelines
Medscape Medical News, October 2, 2018
ESC 2018 Low-Carb Diets Linked to Higher All-Cause Mortality
Medscape Medical News, September 18, 2018
ESC 2018 APAF-CRT: 'Ablate and Pace' for Permanent AF With HF, Narrow QRS
Medscape Medical News, September 12, 2018
ESC 2018 Radiation Dosing at CT Angiography Plunged in Past Decade
Medscape Medical News, September 7, 2018
ESC 2018 AIMS: Irbesartan Slows Marfan's Aortic Dilatation, Lower BP Key?
Medscape Medical News, September 5, 2018
ESC 2018 New ESC Guideline on Cardiovascular Disease in Pregnancy
Medscape Medical News, September 5, 2018
ESC 2018 MATRIX: Transradial Access Benefits Maintained at 1 Year
Medscape Medical News, September 4, 2018
ESC 2018 High-Sensitivity Troponin Does Not Improve MI Outcomes
Medscape Medical News, September 4, 2018
ESC 2018 Drug-Coated Balloon in Line With DES in Small De Novo Lesions
Medscape Medical News, August 31, 2018
ESC 2018 VERDICT: No Advantage of Early Invasive Strategy in NSTE-ACS
Medscape Medical News, August 29, 2018
ESC 2018 FREED: Febuxostat in Hyperuricemia Shields Kidneys, CV Risk Unclear
Medscape Medical News, August 29, 2018
ESC 2018 PURE Diet Score Recommends 7 Foods, Including Dairy and Meat
Medscape Medical News, August 29, 2018
ESC 2018 Not All TAVR Valves the Same in Producing Embolic Debris
Medscape Medical News, August 29, 2018
ESC 2018 Switch to Oral Antibiotics Safe in Left-Sided Endocarditis
Medscape Medical News, August 29, 2018
ESC 2018 TRICS 3: Restrictive Transfusion Appears Safe in CV Surgery
Medscape Medical News, August 28, 2018
ESC 2018 New ESC/EACTS Guideline on Myocardial Revascularization
Medscape Medical News, August 28, 2018
ESC 2018 TIM-HF2: Remote Patient Management May Improve Outcomes in HF
Medscape Medical News, August 28, 2018

ESC 2018 MITRA-FR: MitraClip Comes Up Empty-Handed in Functional MR
Medscape Medical News, August 28, 2018
ESC 2018 Extended Ticagrelor Monotherapy After Stenting Misses Endpoint
Medscape Medical News, August 27, 2018
ESC 2018 ATTR-ACT: Tafamidis Reduces Mortality in Amyloid Cardiomyopathy
Medscape Medical News, August 27, 2018
ESC 2018 COMMANDER HF Quashes Oral Anticoagulation Hopes in HF Sans AF
Medscape Medical News, August 27, 2018
ESC 2018 ASCOT Legacy: Long-term Survival Benefit of BP, Lipid Lowering
Medscape Medical News, August 27, 2018
ESC 2018 ART: Did Bilateral IMA Bypass Grafts Miss Mark at 10 Years?
Medscape Medical News, August 27, 2018
ESC 2018 Omega-3 Supplements: No Effect on Vascular Events in ASCEND
Medscape Medical News, August 27, 2018
ESC 2018 ASCEND: Aspirin Not Needed for Primary Prevention in Diabetes
Medscape Medical News, August 27, 2018
ESC 2018 No Reduction in VTE, Death With Rivaroxaban Post-Discharge
Medscape Medical News, August 26, 2018
ESC 2018 Lorcaserin Is Safe, 'Moves Needle' for Weight Loss in CAMELLIA
Medscape Medical News, August 26, 2018
ESC 2018 Daily Aspirin Fails as Primary Prevention in ARRIVE Trial
Medscape Medical News, August 26, 2018
ESC 2018 Fourth Universal Definition Separates MI From Myocardial Injury
Medscape Medical News, August 26, 2018
ESC 2018 SCOT-HEART: CT Angiography Linked to Less CAD Death, Nonfatal MI
Medscape Medical News, August 25, 2018
ESC 2018 Oral Anticoagulation Protects TAVR Valves: FRANCE-TAVI Registry
Medscape Medical News, August 25, 2018
ESC 2018 Benefit Persists for Culprit-Lesion-Only PCI in MI With Shock
Medscape Medical News, August 25, 2018
ESC 2018 ESC Congress 2018: New Guidelines, MI Redefined, Preventive ASA
Medscape Medical News, August 20, 2018

© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Perspectives From ESC

Coronary Microvascular Dysfunction: Common Finding in HFpEF
Ileana L. Piña, MD, MPH; Carolyn S.P. Lam, MBBS, PhD
COMMANDER HF: What Now for Anticoagulation in Heart Failure?
Ileana L. Piña, MD, MPH; Mandeep R. Mehra, MBBS
PURE and Simple Diet Lowers Mortality, CVD Events
Interviewer: John M. Mandrola, MD;
Interviewee: Andrew Mente, PhD
Will GLOBAL LEADERS Change Dual Antiplatelet Therapy Regimens?
Adnan Kastrati, MD; Christopher B. Granger, MD
Aspirin for Primary Prevention in People With Diabetes: Lessons From ASCEND
Interviewer: John M. Mandrola, MD;
Interviewee: Jane M. Armitage, MBBS, FRCP, FFPH
Fish Oils Off the Menu for People With Diabetes
Interviewer: Melissa Walton-Shirley, MD;
Interviewee: Louise Bowman, MD, FRCP
Aspirin in Primary Prevention: Lessons From ARRIVE
Interviewer: John M. Mandrola, MD;
Interviewee: J. Michael Gaziano, MD, MPH

Bloggers From the Floor

Don't Ignore the Many Lessons of the MitraClip Failure Reflecting on the MITRA-FR trial, Dr John Mandrola says it can help us learn both specific lessons about the treatment of people with heart failure and more general lessons on the acceptance of untested therapeutics.
Ten Things I Learned About Aspirin at ESC Two neutral trials inform an everyday clinical question: who should take aspirin for primary prevention of cardiovascular disease. John Mandrola spoke with both investigators; these are his takeaways.
Five Reasons I Don't Believe an Imaging Test Improves Outcomes The SCOT-HEART presentation at ESC 2018 contends that CT angiography can lead to fewer events at 5 years in patients with stable chest pain. John Mandrola remains unconvinced.
Mandrola's ESC 2018 Preview From aspirin to VTE, John Mandrola reflects on the potpourri of relevant data for the practicing clinician at this year's European Society of Cardiology Congress.

Do Cardiologists Care About CV Prevention? Everyone agrees that prevention is better than cure. However, few ESC attendees joined Melissa Walton-Shirley for the session on CVD prevention, preferring to stand in line to hear the latest hotlines.
Cardiology 2028: Predicting the Future Melissa Walton-Shirley attended a session at the European Society of Cardiology Congress titled "Cardiology 10 Years From Now" and heard some realistic predictions.
What's Driving Physician Burnout in 2018? At a session on burnout at the ESC meeting in Munich, Dr Walton-Shirley heard a first-hand account of a cardiologist who had a breakdown. The panelists left her hopeful that things will improve.
Overprescribing in the Elderly: We Have a Problem Melissa Walton-Shirley sat in on a presentation about polypharmacy in older patients and learned some surprising statistics.